Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study of PCUR-101 in Combination With ADT in Patients With mCRPC
Phase 1
Terminated
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Pellficure Pharmaceuticals, Inc
- Target Recruit Count
- 7
- Registration Number
- NCT04677855
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Nebraska Cancer Specialist, Omaha, Nebraska, United States
🇦🇺St. George Private Hospital, Kogarah, New South Wales, Australia
A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 1
Terminated
- Conditions
- Metastatic Castration-Resistant Prostate Cancer
- Interventions
- Drug: PCUR - 101
- First Posted Date
- 2017-05-03
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Pellficure Pharmaceuticals, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT03137758
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
News
No news found